Work

An Airway-Centric View of Idiopathic Pulmonary Fibrosis

Year: 2022

Type: article

Source: American Journal of Respiratory and Critical Care Medicine

DOI: 10.1164/rccm.202109-2219pp

Authors: Ian T. Stancil, Jacob E. Michalski, David A. Schwartz

Institution: University of Colorado Anschutz

Language: English

Topic: Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: U.S. Department of Defense, U.S. Department of Veterans Affairs, National Institute on Aging, National Heart, Lung, and Blood Institute

Awards: G2904642737, G2961667275, MUC5B, a novel therapeutic target for Idiopathic Pulmonary Fibrosis (IPF), Preclinical Pulmonary Fibrosis, an opportune rare disease cohort, G4114237284, G446473160, G5106082351, Genes and Transcripts that Interact with MUC5B in Pulmonary Fibrosis, MUC5B, a novel therapeutic target for Idiopathic Pulmonary Fibrosis (IPF), IDIOPATHIC PULMONARY FIBROSIS, A DISEASE INITIATED BY MUCOCILIARY DYSFUNCTION, Preclinical Pulmonary Fibrosis, an opportune rare disease cohort, Integrative Physiology of Aging Training Grant, Molecular Determinants of Usual Interstitial Pneumonia (UIP), Stanford Training Program in Lung Biology

OpenAlex ID: W4224265058

FWCI: 2.257

Cites: 57

Cited by: 18

Related to: 10